• Explore /
  • Poster
  • / Safety and efficacy of PIPAC in ovarian cancer patients with peritoneal metastases: A first-in-US phase I study.

Safety and efficacy of PIPAC in ovarian cancer patients with peritoneal metastases: A first-in-US phase I study.

Abstract Poster

Authors

null

Rosemary Senguttuvan

City of Hope National Medical Center, Duarte, CA

Rosemary Senguttuvan , Daphne B. Stewart , Edward Wenge Wang , Nora Ruel , Paul Henry Frankel , Yanghee Woo , Isaac Benjamin Paz , Yuman Fong , Sue Chang , Melissa Eng , Raechelle Tinsley , Joanne E. Mortimer , Richard L Whelan , Jeannine Villela , Amit Merchea , Mihaela C. Cristea , Mustafa Raoof , Sarah Cole , Thanh Hue Dellinger

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Clinical Trial Registration Number

NCT04329494

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 5554)

DOI

10.1200/JCO.2023.41.16_suppl.5554

Abstract #

5554

Poster Bd #

249

Abstract Disclosures

Similar Posters

First Author: S.P. Somashekhar

First Author: Raghav Sundar

First Author: Vladimir Khomiakov

First Author: Florian Struller